4 - Inside ESG: Sustainable finance and the threat to divest
If you want your investments to match your principles should a threat to divest be part of your long-term strategy? In the fourth episode of our special five-part series on sustainable or ESG investin...
20 Okt 202124min
3 - Inside ESG: The tiny fund that took on a US giant and won
The story of how a tiny, unknown hedge fund took on a giant of corporate America over climate change - and won. Charlie Penner of Engine No 1 talks about the very public proxy campaign he launched aga...
6 Okt 202119min
2 - Inside ESG: Can businesses really marry profit and purpose?
Milton Friedman, the renowned American economist and spiritual mentor of many entrepreneurs, argued that the social responsibility of business was to increase profits. This has been the gospel since t...
23 Sep 202122min
1 - Inside ESG: Is the $1.7tn wave of sustainable investing hope or hype?
When Tariq Fancy joined BlackRock as its first chief investment officer for sustainable investing in 2018, he was convinced that with companies around the world, including the world’s biggest asset ma...
23 Sep 202123min
Trailer: Inside ESG
Behind the Money presents a special 5-part series produced in partnership with the FT’s Moral Money team that goes inside the colossal sums flowing into sustainable investing.Trillions have flooded in...
22 Sep 20211min
Introducing Tech Tonic: You Can’t Always Get What you Quant
Introducing the FT Tech Tonic podcast. You can subscribe and listen to the rest of the series here.From picking the best stocks to listening in on earnings calls, AI-powered systems are changing finan...
19 Jul 202128min
Financial services after Brexit
The City of London is home to some of the world’s biggest banks and busiest exchanges but the UK is just weeks away from leaving the EU single market and many questions about access to the bloc are st...
9 Des 202022min
Moderna’s race to the vaccine
The Boston-based biotech eschewed a traditional approach to vaccine development, instead pitching its use of mRNA technology to investors. That pitch paid off this year as the company stands to be one...
2 Des 202019min
